• LAST PRICE
    406.9200
  • TODAY'S CHANGE (%)
    Trending Down-44.1600 (-9.7898%)
  • Bid / Lots
    406.0000/ 1
  • Ask / Lots
    406.7000/ 1
  • Open / Previous Close
    430.0000 / 451.0800
  • Day Range
    Low 404.7400
    High 430.0000
  • 52 Week Range
    Low 372.5000
    High 583.3900
  • Volume
    2,006,499
    above average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

  • Today

      Show headlines and story abstract
    • 5 hours ago by Dow Jones
      Companies Mentioned: IDXX
      September 30, September 30, 2024 2023 -------------------- ---------------- ----------------- Cash Flows from Operating Operating: Activities: Net income $671,718 $650,521 Non-cash adjustments to net income 119,761 120,390 Changes in assets and liabilities (124,503) (114,252) --------------------- ---------- ------------ ------------- Net cash provided by operating activities 666,976 656,659 --------------------- ---------- ------------ ------------- Cash Flows from Investing Investing: Activities: Purchases of property and equipment (91,667) (101,075) Acquisition of a business (76,694) -- Proceeds from net investment hedges 1,142 6,256 --------------------- ---------- ------------ ------------- Net cash used by investing activities (167,219) (94,819) Cash Flows from Financing Financing: Activities: Repayments under credit facility, net -- (329,000) Payments of senior notes (75,000) -- Payments for the acquisition-related holdbacks -- (1,879) Repurchases of common stock (591,042) (35,070) Proceeds from exercises of stock options and employee stock purchase plans 31,237 35,704 Shares withheld for statutory tax withholding payments on restricted stock (10,486) (9,907) ------------ ------------- Net cash used by financing activities (645,291) (340,152) --------------------- ---------- ------------ ------------- Net effect of changes in exchange rates on cash 238 (2,538) Net (decrease) increase in cash and cash equivalents (145,296) 219,150 Cash and cash equivalents, beginning of period 453,932 112,546 --------------------- ---------- ------------ ------------- Cash and cash equivalents, end of period $308,636 $331,696 --------------------- ---------- ------------ ------------- IDEXX Laboratories, Inc. and Subsidiaries Free Cash Flow Amounts in thousands (Unaudited) Three Months Ended Nine Months Ended -------------------------- -------------------------- September September September September 30, 2024 30, 2023 30, 2024 30, 2023 ------------- ------------ ------------ ------------ ------------ Net cash Free provided by Cash operating Flow: activities $220,079 $272,433 $666,976 $656,659 Investing cash flows attributable to purchases of property and equipment (28,089) (34,094) (91,667) (101,075) -------------- -------- -------- -------- -------- Free cash flow(1) $191,990 $238,339 $575,309 $555,584 -------------- -------- -------- -------- -------- (1) See Statements Regarding Non-GAAP Financial Measures, above. IDEXX Laboratories, Inc. and Subsidiaries Common Stock Repurchases Amounts in thousands except per share data (Unaudited) Three Months Ended Nine Months Ended -------------------------- -------------------------- September September September September 30, 2024 30, 2023 30, 2024 30, 2023 -------------- ------------ ------------ ------------ ------------ Shares repurchased in the open market 459 65 1,177 65 Shares acquired through employee surrender for statutory tax withholding 1 1 19 20 ------------ ------------ ------------ ------------ Total shares repurchased 460 66 1,196 85 ============ ============ ============ ============ Cost of shares repurchased in the open market $224,945 $35,070 $600,216 $35,070 Cost of shares for employee surrenders 218 231 10,486 9,907 ------------ ------------ ------------ ------------ Total cost of shares $225,163 $35,301 $610,702 $44,977 ============ ============ ============ ============ Average cost per share -- open market repurchases $490.23 $536.03 $509.81 $536.03 Average cost per share -- employee surrenders $465.27 $506.74 $557.64 $503.43 Average cost per share -- total $490.20 $535.83 $510.57 $528.49 --------------- ------------ ------------ ------------ ------------
    • 6 hours ago by MT Newswires
      Companies Mentioned: IDXX
      01:17 PM EDT, 10/31/2024 (MT Newswires) -- ...
    • 6 hours ago by Dow Jones
      Companies Mentioned: IDXX
      September 30, September 30, 2024 2023 -------------------- ---------------- ----------------- Cash Flows from Operating Operating: Activities: Net income $671,718 $650,521 Non-cash adjustments to net income 119,761 120,390 Changes in assets and liabilities (124,503) (114,252) --------------------- ---------- ------------ ------------- Net cash provided by operating activities 666,976 656,659 --------------------- ---------- ------------ ------------- Cash Flows from Investing Investing: Activities: Purchases of property and equipment (91,667) (101,075) Acquisition of a business (76,694) -- Proceeds from net investment hedges 1,142 6,256 --------------------- ---------- ------------ ------------- Net cash used by investing activities (167,219) (94,819) Cash Flows from Financing Financing: Activities: Repayments under credit facility, net -- (329,000) Payments of senior notes (75,000) -- Payments for the acquisition-related holdbacks -- (1,879) Repurchases of common stock (591,042) (35,070) Proceeds from exercises of stock options and employee stock purchase plans 31,237 35,704 Shares withheld for statutory tax withholding payments on restricted stock (10,486) (9,907) ------------ ------------- Net cash used by financing activities (645,291) (340,152) --------------------- ---------- ------------ ------------- Net effect of changes in exchange rates on cash 238 (2,538) Net (decrease) increase in cash and cash equivalents (145,296) 219,150 Cash and cash equivalents, beginning of period 453,932 112,546 --------------------- ---------- ------------ ------------- Cash and cash equivalents, end of period $308,636 $331,696 --------------------- ---------- ------------ ------------- IDEXX Laboratories, Inc. and Subsidiaries Free Cash Flow Amounts in thousands (Unaudited) Three Months Ended Nine Months Ended -------------------------- -------------------------- September September September September 30, 2024 30, 2023 30, 2024 30, 2023 ------------- ------------ ------------ ------------ ------------ Net cash Free provided by Cash operating Flow: activities $220,079 $272,433 $666,976 $656,659 Investing cash flows attributable to purchases of property and equipment (28,089) (34,094) (91,667) (101,075) -------------- -------- -------- -------- -------- Free cash flow(1) $191,990 $238,339 $575,309 $555,584 -------------- -------- -------- -------- -------- (1) See Statements Regarding Non-GAAP Financial Measures, above. IDEXX Laboratories, Inc. and Subsidiaries Common Stock Repurchases Amounts in thousands except per share data (Unaudited) Three Months Ended Nine Months Ended -------------------------- -------------------------- September September September September 30, 2024 30, 2023 30, 2024 30, 2023 -------------- ------------ ------------ ------------ ------------ Shares repurchased in the open market 459 65 1,177 65 Shares acquired through employee surrender for statutory tax withholding 1 1 19 20 ------------ ------------ ------------ ------------ Total shares repurchased 460 66 1,196 85 ============ ============ ============ ============ Cost of shares repurchased in the open market $224,945 $35,070 $600,216 $35,070 Cost of shares for employee surrenders 218 231 10,486 9,907 ------------ ------------ ------------ ------------ Total cost of shares $225,163 $35,301 $610,702 $44,977 ============ ============ ============ ============ Average cost per share -- open market repurchases $490.23 $536.03 $509.81 $536.03 Average cost per share -- employee surrenders $465.27 $506.74 $557.64 $503.43 Average cost per share -- total $490.20 $535.83 $510.57 $528.49 --------------- ------------ ------------ ------------ ------------
    • 7 hours ago by Dow Jones
      Companies Mentioned: IDXX

      IDEXX Laboratories, Inc. (IDXX) is currently at $406.08, down $45.00 or 9.97%

      --Would be lowest close since Nov. 1, 2023, when it closed at $395.35

      --On pace for largest percent decrease since March 16, 2020, when it fell 11.94%
    • 12 hours ago by MT Newswires
      Companies Mentioned: IDXX
      07:35 AM EDT, 10/31/2024 (MT Newswires) -- IDEXX Laboratories (IDXX) reported Q3 earnings Thursday of $2.80 per share, up from $2.53 a year earlier. Analysts polled by Capital IQ expected $2.69. Revenue for the quarter ended Sept. 30 was $975.5 mill...

Peers Headlines